Related Experiment Video
Updated: Jun 21, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.
Viktor Sincic1,2, Ken F Arlenhold1,2, Sarah Richtmann1,2
1Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.
Cells
|June 19, 2024
Summary
Bladder cancer molecular subtypes significantly impact immune cell composition and T cell exhaustion. Understanding these differences is key for developing targeted immunotherapies for bladder tumors.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Bladder cancer heterogeneity necessitates molecular subtyping for better characterization.
- The immune microenvironment's role in different bladder cancer subtypes remains poorly understood.
Purpose of the Study:
- To analyze the immune compartment, focusing on T cell subpopulations, in relation to bladder cancer molecular subtypes (Lund Taxonomy) and invasiveness.
- To investigate immune cell infiltration and composition differences across molecular subtypes and tumor invasiveness.
Main Methods:
- Flow cytometry and RNA sequencing were employed to analyze immune cells in bladder tumors and normal urothelium.
- T cell subpopulations, including CD8+ T cells and regulatory T cells, were quantified and characterized.
- Results were correlated with tumor invasiveness (non-muscle-invasive vs. muscle-invasive bladder cancer) and molecular subtypes.
Main Results:
- Molecular subtypes, unlike tumor invasiveness alone, showed distinct differences in immune infiltration and composition.
- Basal/Squamous (Ba/Sq) and genomically unstable (GU) subtypes exhibited higher immune infiltration than urothelial-like (Uro) tumors.
- GU tumors had more regulatory T cells, and both GU and Uro tumors showed T cell exhaustion markers (protein level in Uro, transcriptomic in GU).
Conclusions:
- Bladder cancer molecular subtypes significantly influence the tumor immune microenvironment.
- Distinct immune profiles across subtypes suggest the need for tailored immunotherapeutic strategies.
- Targeting specific T cell populations and exhaustion pathways may improve treatment efficacy based on molecular subtype.

